 |
|
|
||||||||||||||
 |
|
|
One simple test could change the future
The test is intended for use by physicians as an aid in management of patients considered to be at risk for Type 2 diabetes.
The PreDx™ Diabetes Risk Test is performed using a routine fasting blood sample. It quantifies a panel of biomarkers, resulting in a single score: the PreDx™ Diabetes Risk Score. The biomarkers used in the PreDx Diabetes Risk Test were selected by testing baseline samples from individuals 30 to 60 years of age who developed diabetes within 5 years and a random selection of controls from the same population.1-3 Using mathematical modeling, the PreDx Diabetes Risk Test combines multiple biomarkers into a single diabetes risk factor between 1 (least risk) and 10 (highest risk).2
NOTE: The PreDx Diabetes Risk Test is an adjunctive test to complement, not replace, other diagnostic and clinical procedures.
The PreDx™ Diabetes Risk Score may be used as a motivational tool in helping to increase patient compliance for those at high risk.
*Performed exclusively by the Tethys Clinical Laboratory
1. Population description: Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation 2003;10:377-386.
2. Data on file, Tethys Clinical Laboratory, Tethys Bioscience, Inc., 2008
3. Kolberg J, Gerwien R, Moler E, Rowe M, Urdea M, McKenna M, Hansen T, Pedersen O, Jørgensen T. Training and validation of a multimarker algorithm for the prediction of Type 2 diabetes from a 5 yr prospective study of 6,784 Danish people (Inter99). American Diabetes Association 68th Scientific Sessions, 2008.
Nov 20, 2008
Tethys Bioscience Joins National Diabetes Goal
Company joins national move to ensure Americans know their risk of developing Type 2 Diabetes.
Sep 17, 2008
Tethys Bioscience Announces Acquisition of Lipomics Technologies
Addition of metabolite technology uniquely positions company as it expands its line of predictive diagnostic tests
Jul 2, 2008
Tethys unveils advanced-warning test for diabetes by Michael Fitzhugh
Tethys Bioscience Inc. is launching a new test that can identify people at high risk of developing Type 2 diabetes within five years - allowing them to take steps to reduce their risk.
(East Bay Business Times Friday, June 13, 2008)
Jul 2, 2008
A Predictive Tool for Diabetes By Thomas Goetz
Thomas Goetz, deputy editor of Wired magazine, wrote about Tethys and the PreDx Diabetes Risk Test on his personal blog, which tracks trends and technologies in medicine and health.
(Epidemix.org)
Jun 9, 2008
Diabetes test gives 5-year disease-prediction window.
There is an old saying that seems appropriate when describing Tethys Bioscience's PreDx Diabetes Risk Test: Forewarned is forearmed.
(Medical Device Daily)
Jun 7, 2008
Tethys Bioscience Announces Expanded Availability of PreDx™ Diabetes Risk Test
A Powerful New Tool for Early Identification of High Risk Patients
Early Intervention Can Help Prevent Disease Progression